Zhejiang Jolly Pharmaceutical Co.,LTD (SHE:300181)

Market Cap	10.55B -6.9%
Revenue (ttm)	3.11B +14.1%
Net Income	650.37M +19.0%
EPS	0.94 +19.2%
Shares Out	693.22M
PE Ratio	16.25
Forward PE	n/a
Dividend	0.60 (3.94%)
Ex-Dividend Date	May 26, 2025

Volume	13,353,951
Average Volume	11,336,715
Open	15.37
Previous Close	15.21
Day's Range	15.11 - 15.39
52-Week Range	14.81 - 21.07
Beta	0.22
RSI	42.60
Earnings Date	Apr 27, 2026

About SHE:300181

Zhejiang Jolly Pharmaceutical Co.,LTD engages in the research, production, and marketing of Chinese medicinal products in the People’s Republic of China and internationally. It offers Wuling capsule to treat insomnia, amnesia, heart palpitations, lack of energy, lassitude in loin and legs, and giddy tinnitus, as well as deficiency of energy and weak pulse caused by the disharmony of heart and kidney, or neurasthenia. The company also provides Lingze tablet, which is used to treat frequent urination, dysuria, weak steam of urine, endless urine, ...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1995
• Employees: 2,125
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300181

Financial Performance

In 2025, SHE:300181's revenue was 3.04 billion, an increase of 17.96% compared to the previous year's 2.58 billion. Earnings were 631.93 million, an increase of 24.45%.